Eye News and Research

Latest Eye News and Research

Researchers find ranibizumab drug as effective alternative to laser therapy for treating diabetic retinopathy

In a randomized clinical trial of more than 300 participants, researchers from Johns Hopkins and elsewhere have found that ranibizumab — a drug most commonly used to treat retinal swelling in people with diabetes — is an effective alternative to laser therapy for treating the most severe, potentially blinding form of diabetic retinal disease. Results of the government-sponsored study also show that the drug therapy carries fewer side effects than the currently used laser treatment.

17 Nov 2015

Ranibizumab may become reasonable treatment alternative for patients with proliferative diabetic retinopathy

Among patients with proliferative diabetic retinopathy, treatment with an injection in the eye of the drug ranibizumab resulted in visual acuity that was not worse than panretinal photocoagulation at 2 years, according to a study appearing in JAMA.

15 Nov 2015

Study: Programmable electronic glasses help improve vision in children diagnosed with lazy eye

A new study on lazy eye found that programmable electronic glasses help improve vision in children just as well as the more traditional treatment using eye patches. This "digital patch" is the first new effective treatment for lazy eye in half a century. Results from the first U.S. trial of this device will be presented at AAO 2015, the 119th Annual Meeting of the American Academy of Ophthalmology.

15 Nov 2015

Presence of connexin proteins suppresses primary tumor growth

How does a protein called connexin put the clamps on cancer? Researchers in the School of Medicine at The University of Texas Health Science Center at San Antonio today reported an explanation.

13 Nov 2015

U of I scientists show that tomato component reduces growth of prostate tumors in animal models

Years of research in University of Illinois scientist John Erdman's laboratory have demonstrated that lycopene, the bioactive red pigment found in tomatoes, reduces growth of prostate tumors in a variety of animal models. Until now, though, he did not have a way to trace lycopene's metabolism in the human body.

13 Nov 2015

AAO recognizes outstanding eye physicians and surgeons for innovation in patient care

The American Academy of Ophthalmology will pay tribute to outstanding eye physicians and surgeons who have made significant achievements in various areas of the profession. These range from scientific innovation and humanitarian service to education and advocacy. The honorees will be recognized AAO 2015, the Academy's 119th annual meeting in Las Vegas.

13 Nov 2015

AAO announces launch of new online resource to improve eye care for children

The American Academy of Ophthalmology today announced the launch of a new online resource for eye physicians and surgeons dedicated solely to children's ocular diseases and disorders. The Knights Templar Eye Foundation Pediatric Ophthalmology Education Center is an important tool that enables ophthalmologists to better serve the 19 million children worldwide who suffer visual impairment. The new resource will be unveiled this week at AAO 2015, the 119th annual meeting of the American Academy of Ophthalmology.

12 Nov 2015

Special orchestra boosts mood and confidence in patients with dementia

A special orchestra for people with dementia has helped boost their confidence and mood, according to a new research project.

11 Nov 2015

Lowering blood pressure below currently recommended targets reduces risk of stroke, heart attack

Using intensive treatment to lower blood pressure below currently recommended targets significantly reduces rates of major cardiovascular events like stroke and heart attack among a wide range of high-risk patients, according to a large meta-analysis involving almost 45000 individuals, published in The Lancet.

11 Nov 2015

Cotellic (cobimetinib) approved to be used in combination with vemurafenib for melanoma treatment

The U.S. Food and Drug Administration today approved Cotellic (cobimetinib) to be used in combination with vemurafenib to treat advanced melanoma that has spread to other parts of the body or can't be removed by surgery, and that has a certain type of abnormal gene (BRAF V600E or V600K mutation).

10 Nov 2015

L-DOPA drug may delay or prevent age-related macular degeneration

A drug already used safely to treat Parkinson's disease, restless leg syndrome and other movement disorders also could delay or prevent the most common cause of blindness affecting more than 9 million older Americans - age-related macular degeneration (AMD).

10 Nov 2015

Dusseldorf will be the meeting point for MEDICA and COMPAMED this week

In the coming week, from 16 to 19 November 2015, Düsseldorf will again become the central meeting point of the international health business. Then, for the first time on the new set of dates from Monday to Thursday (previously: Wednesday to Saturday), the world’s largest medical trade fair, MEDICA, and the international leading supplier specialist trade fair, COMPAMED taking place at the same time, are going to start.

9 Nov 2015

Touch Surgery Officially The Largest Worldwide Community Of Surgeons Practicing Surgery Virtually

Digital Surgical Simulator Touch Surgery Collaborates with Experts Surgeons at International Institutions (Stanford, Yale, Dartmouth, Vanderbilt, Imperial College London, Singapore National Eye Center & Others) to Create Simulations of Surgical Best Practices.

6 Nov 2015

Better visualization in complex reconstructive surgery with ZEISS Opmi Pentero 800 surgical microscope

The capabilities of the OPMI® PENTERO® 800 surgical microscopes from ZEISS for reconstructive surgery have been enhanced by the introduction of the INFRARED 800 module.

From Carl Zeiss Microscopy GmbH 6 Nov 2015

UCSF scientists identify eye drop chemical that may reverse cataracts

A chemical that could potentially be used in eye drops to reverse cataracts, the leading cause of blindness, has been identified by a team of scientists from UC San Francisco (UCSF), the University of Michigan (U-M), and Washington University in St. Louis (WUSTL).

6 Nov 2015

Boxing more dangerous than mixed martial arts, shows study

Mixed martial arts has a reputation for being one of the most brutal and bloody of all contact sports, but the reality is boxing poses a greater risk of serious injury, according to new research from the University of Alberta.

6 Nov 2015

Men exposed to domestic violence more worried about not being believed

Men who receive help from crisis centres are mostly satisfied with the help they get. But they fear that nobody will believe that they've been abused by a woman.

6 Nov 2015

RXi Pharmaceuticals begins Phase 1/2 clinical trial in ophthalmology

RXi Pharmaceuticals Corporation a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology today announced the initiation of a Phase 1/2 clinical trial in ophthalmology. The clinical study RXI-109-1501 will evaluate the safety and clinical activity of RXI-109 to prevent the progression of retinal scarring, a harmful component of numerous retinal diseases.

5 Nov 2015

UConn-led researchers develop simple technique for diagnosis and monitoring of sickle cell disease

A team of UConn biomedical engineers, working with colleagues from Yale, MIT, and Harvard, has developed a simple, inexpensive, and quick technique for the diagnosis and monitoring of sickle cell disease that can be used in regions where advanced medical technology and training are scarce.

5 Nov 2015

Study suggests need for specific treatment options for adolescents with onset type 2 diabetes

New results from the Treatment Options for Type 2 Diabetes in Youth study (TODAY) examined predictors of the outcomes in youth with onset type 2 diabetes (T2D) based on early characteristics at diagnosis, and suggests the need for specific criteria for adolescents that are different from those in adults.

5 Nov 2015

Eye News and Research

Latest Eye News and Research

Researchers find ranibizumab drug as effective alternative to laser therapy for treating diabetic retinopathy

Ranibizumab may become reasonable treatment alternative for patients with proliferative diabetic retinopathy

Study: Programmable electronic glasses help improve vision in children diagnosed with lazy eye

Presence of connexin proteins suppresses primary tumor growth

U of I scientists show that tomato component reduces growth of prostate tumors in animal models

AAO recognizes outstanding eye physicians and surgeons for innovation in patient care

AAO announces launch of new online resource to improve eye care for children

Special orchestra boosts mood and confidence in patients with dementia

Lowering blood pressure below currently recommended targets reduces risk of stroke, heart attack

Cotellic (cobimetinib) approved to be used in combination with vemurafenib for melanoma treatment

L-DOPA drug may delay or prevent age-related macular degeneration

Dusseldorf will be the meeting point for MEDICA and COMPAMED this week

Touch Surgery Officially The Largest Worldwide Community Of Surgeons Practicing Surgery Virtually

Better visualization in complex reconstructive surgery with ZEISS Opmi Pentero 800 surgical microscope

UCSF scientists identify eye drop chemical that may reverse cataracts

Boxing more dangerous than mixed martial arts, shows study

Men exposed to domestic violence more worried about not being believed

RXi Pharmaceuticals begins Phase 1/2 clinical trial in ophthalmology

UConn-led researchers develop simple technique for diagnosis and monitoring of sickle cell disease

Study suggests need for specific treatment options for adolescents with onset type 2 diabetes

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Eye News and Research

Latest Eye News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in